Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity Article

cited authors

  • Rudolph, Joachim; Esler, William P.; O'Connor, Stephen; Coish, Philip D. G.; Wickens, Philip L.; Brands, Michael; Bierer, Donald E.; Bloomquist, Brian T.; Bondar, Georgiy; Chen, Libing; Chuang, Chih-Yuan; Claus, Thomas H.; Fathi, Zahra; Fu, Wenlang; Khire, Uday R.; Kristie, James A.; Liu, Xiao-Gao; Lowe, Derek B.; McClure, Andrea C.; Michels, Martin; Ortiz, Astrid A.; Ramsden, Philip D.; Schoenleber, Robert W.; Shelekhin, Tatiana E.; Vakalopoulos, Alexandros; Tang, Weifeng; Wang, Lei; Yi, Lin; Gardell, Stephen J.; Livingston, James N.; Sweet, Laurel J.; Bullock, William H.

Publication Date

  • October 18, 2007

webpage

published in

category

start page

  • 5202

end page

  • 5216

volume

  • 50

issue

  • 21